VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. VectivBio Holding AG market cap is $1.06B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. VectivBio Holding AG 52 week high is $16.98 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. VectivBio Holding AG 52 week low is $4.25 as of November 15, 2026.
VectivBio Holding AG stock price today is $16.85.
VectivBio Holding AG stock price yesterday was $16.85.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. VectivBio Holding AG's P/E ratio is -7.93.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. VectivBio Holding AG P/B ratio is 4.9546.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. VectivBio Holding AG 50-day moving average is $14.67.
